Six-year-old Thomas was first diagnosed with a rare brain cancer at the age of two and after undergoing years of treatment his parents John and Abigail learnt that his cancer had returned.
Faced with no other treatment options other than invasive surgery Thomas was recommended by his Oncologist to the ZERO program, a life-saving children’s cancer research program which uses genetic testing to find treatments that shrink or stabilise aggressive tumours in children.
Thomas entered a clinical trial for a drug normally used to treat lung cancer called Afatinib. His parents John and Abigail quickly noticed changes in Thomas once he started to receive the medication and soon he started to return to normal activities. Read more